NuCana

$4.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+0.90%) Today
$0.00 (0.00%) As of 10:03 AM UTC after-hours

Why Robinhood?

You can buy or sell NuCana and other stocks, options, and ETFs commission-free!

About NCNA

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom. The listed name for NCNA is NuCana plc American Depositary Share.

CEO
Hugh Stephen Griffith
Employees
31
Headquarters
Edinburgh, Midlothian
Founded
1997
Market Cap
143.91M
Price-Earnings Ratio
Dividend Yield
Average Volume
116.11K
High Today
$4.58
Low Today
$4.44
Open Price
$4.44
Volume
93.78K
52 Week High
$10.59
52 Week Low
$3.81

Collections

NCNA Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.31 per share

You May Also Like